aap Implantate AG

Earnings Release • Apr 3, 2013

News Details

Ad-hoc | 3 April 2013 13:31

aap Implantate AG: Increased EBITDA-Forecast for Q1 to EUR 3.1 million

aap Implantate AG / Key word(s): Quarter Results

03.04.2013 13:31

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Preliminary figures show that aap Implantate AG (XETRA: AAQ.DE) increased
the EBITDA in the first quarter of the financial year 2013 to around EUR
3.1 million, up by 48% on the previous year's EUR 2.1 million, while sales
totalling around EUR 10.4 million (previous year: EUR 9.9 million). Its
previous EBITDA forecast was between EUR 1.5 million and EUR 1.9 million.
The EBITDA increase was due to the favourable development of achieving
milestones sooner than expected.
For the full financial year 2013, the Management Board reaffirms for now
its sales growth forecast of at least 10% to around EUR 40.0 million and
its EBITDA growth forecast of at least 15% to over EUR 7.0 million. As
already noted in the consolidated financial statements, quarterly
fluctuations in growth and profitability are to be expected in view of the
product and project sales mix.
Publication of the interim report for the first quarter of 2013 is
scheduled for 15 May 2013.

This release contains forward-looking statements based on current
experience, estimates and projections of the management board and currently
available information. They are not guarantees of future performance.
Various known and unknown risks, uncertainties and other factors could lead
to material differences between the actual future results, financial
situation, development or performance of the company and the estimates
given here. Many factors could cause the actual results, performance or
achievements of aap to be materially different from those that may be
expressed or implied by such statements. These factors include those
discussed in aap's public reports. Forward-looking statements therefore
speak only as of the date they are made. aap does not assume any obligation
to update the forward-looking statements contained in this release or to
conform them to future events or developments.

Contact:
Contact:
aap Implantate AG; Marc Heydrich; Investor Relations; Lorenzweg 5; D-12099
Berlin Tel.: ++49/30/750 19 - 134; Fax.: ++49/30/750 19 - 290;
m.heydrich@aap.de

03.04.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: aap Implantate AG
Lorenzweg 5
12099 Berlin
Germany
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: info@aap.de
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart

End of Announcement DGAP News-Service

---